- Home
- ACTG vs TRDA Comparison
ACTG vs TRDA Comparison
Compare ACTG & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACTG
- TRDA
- Stock Information
- Founded
- ACTG 1993
- TRDA 2016
- Country
- ACTG United States
- TRDA United States
- Employees
- ACTG N/A
- TRDA N/A
- Industry
- ACTG Multi-Sector Companies
- TRDA Biotechnology: Pharmaceutical Preparations
- Sector
- ACTG Miscellaneous
- TRDA Health Care
- Exchange
- ACTG Nasdaq
- TRDA Nasdaq
- Market Cap
- ACTG 363.5M
- TRDA 336.6M
- IPO Year
- ACTG 1996
- TRDA 2021
- Fundamental
- Price
- ACTG $3.73
- TRDA $7.60
- Analyst Decision
- ACTG
- TRDA Strong Buy
- Analyst Count
- ACTG 0
- TRDA 3
- Target Price
- ACTG N/A
- TRDA $25.67
- AVG Volume (30 Days)
- ACTG 263.8K
- TRDA 144.1K
- Earning Date
- ACTG 05-08-2025
- TRDA 05-08-2025
- Dividend Yield
- ACTG N/A
- TRDA N/A
- EPS Growth
- ACTG N/A
- TRDA N/A
- EPS
- ACTG N/A
- TRDA 0.61
- Revenue
- ACTG $222,414,000.00
- TRDA $172,220,000.00
- Revenue This Year
- ACTG $141.36
- TRDA N/A
- Revenue Next Year
- ACTG N/A
- TRDA N/A
- P/E Ratio
- ACTG N/A
- TRDA $12.50
- Revenue Growth
- ACTG 65.22
- TRDA 5.74
- 52 Week Low
- ACTG $2.70
- TRDA $7.10
- 52 Week High
- ACTG $5.74
- TRDA $21.79
- Technical
- Relative Strength Index (RSI)
- ACTG 57.69
- TRDA 39.41
- Support Level
- ACTG $3.58
- TRDA $7.42
- Resistance Level
- ACTG $3.87
- TRDA $8.05
- Average True Range (ATR)
- ACTG 0.13
- TRDA 0.40
- MACD
- ACTG 0.00
- TRDA -0.02
- Stochastic Oscillator
- ACTG 36.59
- TRDA 10.78
About ACTG Acacia Research Corporation (Acacia Tech)
Acacia Research Corp is focused on acquiring and operating businesses across the industrial, energy, and technology sectors where it believes it can leverage its expertise, capital base, and deep industry relationships to drive value. The company has four reportable business segments: Intellectual Property Operations, Industrial Operations, Energy Operations and Manufacturing Operations. It derives revenue from Intellectual Property Operations segment. Geographically, it operates in Americas, Europe, Middle East and Africa, China, India, and Asia-Pacific, excluding China and India.
About TRDA Entrada Therapeutics Inc.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.